Dravet Syndrome Indication Will Set GW Pharma Apart On US Epilepsy Market

 
• By Lucie Ellis-Taitt
  
Dravet Syndrome - Medical Report with Composition of Medicaments - Pills, Injections and Syringe
Epidiolex's potential in Dravet syndrome will be its competitive edge • Source: Shutterstock/Tashatuvango
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Neurological

More from Therapeutic Category